FLAM
CRNX

First Light Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

First Light Asset Management’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.9M Buy
1,360,866
+271,196
+25% +$10.1M 3.1% 14
2026
Q1 		$39.6M Sell
1,089,670
-104,593
-9% -$4.67M 3.55% 9
2025
Q4 		$55.6M Buy
1,194,263
+252,747
+27% +$11.3M 4.25% 6
2025
Q3 		$39.2M Buy
941,516
+77,380
+9% +$2.47M 3.7% 6
2025
Q2 		$24.9M Buy
864,136
+8,717
+1% +$269K 3.22% 11
2025
Q1 		$28.7M Sell
855,419
-30,034
-3% -$1.12M 3.28% 11
2024
Q4 		$45.3M Sell
885,453
-58,158
-6% -$3.25M 4.33% 9
2024
Q3 		$48.2M Sell
943,611
-256,897
-21% -$13.2M 4.01% 7
2024
Q2 		$53.8M Sell
1,200,508
-489,669
-29% -$22.6M 4.71% 3
2024
Q1 		$79.1M Sell
1,690,177
-297,595
-15% -$11.6M 6.06% 1
2023
Q4 		$70.7M Buy
1,987,772
+404,443
+26% +$12.4M 5.69% 4
2023
Q3 		$47.1M Buy
1,583,329
+26,107
+2% +$538K 4.47% 6
2023
Q2 		$28.1M Sell
1,557,222
-61,903
-4% -$1.23M 2.2% 15
2023
Q1 		$26M Buy
1,619,125
+289,812
+22% +$5.36M 2.34% 15
2022
Q4 		$24.3M Sell
1,329,313
-17,339
-1% -$306K 2.26% 16
2022
Q3 		$26.4M Buy
1,346,652
+106,043
+9% +$2.16M 2.68% 13
2022
Q2 		$23.1M Buy
1,240,609
+657,842
+113% +$13.1M 2.69% 13
2022
Q1 		$12.8M Buy
582,767
+309,971
+114% +$6.27M 1.13% 29
2021
Q4 		$7.75M Buy
+272,796
New +$6.73M 0.56% 41

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Light Asset Management's CRNX Position: Q2 2026 in Review

First Light Asset Management increased its Crinetics Pharmaceuticals (CRNX) stake by 25% in Q2 2026, buying an estimated $10.1M and bringing the position to 1,360,866 shares worth $50.9M. The position accounts for 3.1% of the portfolio, ranked #14.

First Light Asset Management first reported a position in CRNX in Q4 2021 and has held it in 19 quarters since. The position peaked at $79.1M in Q1 2024. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • First Light Asset Management held 1,360,866 shares of Crinetics Pharmaceuticals worth $50.9M as of Q2 2026.
  • First Light Asset Management bought 271,196 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $10.1M.
  • Crinetics Pharmaceuticals made up 3.1% of First Light Asset Management's portfolio in Q2 2026, its #14 holding.
  • First Light Asset Management first reported a position in Crinetics Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • First Light Asset Management's Crinetics Pharmaceuticals position peaked at $79.1M in Q1 2024.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.